MA
MRNA icon

Momentum Advisors’s Moderna MRNA Stock Holding History

Momentum Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$1.56M Sell
8,662
-28
-0.3% -$4.58K 1.58% 17
2022
Q3 		$1.03M Buy
8,690
+219
+3% +$33.2K 1.14% 24
2022
Q2 		$1.21M Buy
+8,471
New +$1.21M 1.36% 21

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Momentum Advisors's MRNA Position: Q4 2022 in Review

Momentum Advisors reduced its Moderna (MRNA) stake by 0.32% in Q4 2022, selling an estimated $4.58K and leaving 8,662 shares worth $1.56M. The position accounts for 1.58% of the portfolio, ranked #17.

Momentum Advisors first reported a position in MRNA in Q2 2022 and has held it in 3 quarters since. 1,071 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.

  • Momentum Advisors held 8,662 shares of Moderna worth $1.56M as of Q4 2022.
  • Momentum Advisors sold 28 Moderna shares in Q4 2022, an estimated $4.58K.
  • Moderna made up 1.58% of Momentum Advisors's portfolio in Q4 2022, its #17 holding.
  • Momentum Advisors first reported a position in Moderna in Q2 2022 and has held it in 3 quarters since.
  • 1,071 funds tracked by Wall St. Rank held Moderna as of Q4 2022.

Based on Momentum Advisors's 13F filing for Q4 2022, filed 15 Feb 2023.